Natural Capital
Signal active
Investment Firm
Overview
Natural Capital solves problems by bringing capital, technology, and people together.
Highlights
Founded
2019
Industry
Financial Services
Employees
0
Investment
3
Lead Investment
3
Exits
undefined
Stages
Early Stage Venture
Investor Type
Incubator
Location
United States, North America
Contact Information
Social
N/A
Profile Resume
Natural Capital, established in 2019 and headquartered in United States, North America., specializes in Early Stage Venture investments across Artificial Intelligence (AI), Machine Learning, Medical, Manufacturing, Robotics, Industrial, Industrial Automation, Renewable Energy, Venture Capital, Transportation. Their recent investments include Aether Bio, Unless, Amplifier, Ashvattha Therapeutics, Sand Hill Angels. The highest investment round they participated in was $6.0B. Among their most notable exits are Aether Bio and Unless. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Natural Capital has made 3 investments. Their most recent investment was on Aug 15, 2023, when Aether Bio raised $49.0M.
Natural Capital has made 2 diversity investments. Their most recent diversity investment was on May 31, 2020, when Ashvattha Therapeutics raised $22.0M.
investments
3
Diversity investments
2
Lead investments
3
Number of exits
undefined
Investments
3
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 15, 2019 | Ashvattha Therapeutics | Biotechnology | 7.0M |
| May 31, 2020 | Ashvattha Therapeutics | Biotechnology | 22.0M |
| Aug 15, 2023 | Aether Bio | Artificial Intelligence (AI) | 49.0M |
Exits
0
Funding Timeline
Funding rounds
3
Investors
0
Funds
0
Funding Rounds
3
Natural Capital has raised 3 rounds. Their latest funding was raised on Aug 15, 2023 from a Series A - Aether Bio round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 15, 2019 | Series A - Ashvattha Therapeutics | - | 7.0M | - |
| May 31, 2020 | Convertible Note - Ashvattha Therapeutics | - | 22.0M | - |
| Aug 15, 2023 | Series A - Aether Bio | - | 49.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.